On Oct. 21, news broke that Starboard Value took a position in Kenvue. The firm thinks there is an opportunity to improve ...

The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.

Kenvue is guiding for $1.10 to $1.20 in 2024 earnings per share and 2% to 4% organic sales growth. If it achieves the ...

Several of the S&P 500's stocks fit both bills at this time, with a bunch of them boasting the makings of a true "forever" ...

By Jimmy Rice, Money blog editor Next week will be dominated by what Rachel Reeves says at the dispatch box at 12.30pm on Wednesday as she delivers what's expected to be a painful budget. Amid all ...

Sky News has contacted Unilever for comment. The UK's public sector debt has hit 100% of the value of the country's annual economic output for the first time since the 1960s, according to official ...

Shares of Tata Technologies dropped 3.4% to a day's low of Rs 1,074.2 in Monday's trade on the BSE after global brokerage firm Citi maintained its 'Sell' rating on the stock. Citi, however, raised the ...

The stock quoted a 52-week high of Rs 6276.2 and a 52-week low of Rs 3300.0.